[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354086-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354086-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-catalogue-of-missense-and-nonsense-mutation-abundances-for-the-us-cancer-patient-population","A catalogue of missense and nonsense mutation abundances for the U.S. cancer patient population","","Widespread genomic sequencing efforts have mapped key molecular drivers across multiple cancer types. By integrating these genomic data proportionally to population-level cancer abundances, the study estimates overall abundances for each observed missense and nonsense mutation within the U.S. cancer patient population. The most common variants reported include BRAFV600E at 5.2%, TP53 R175H at 1.5%, and APC R876X at 0.4%, with substantial differences from typical pan-cancer analyses. Full ordered mutation abundance lists support analysis of high-priority genes and pathways, serving basic, translational, and clinical cancer research communities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-catalogue-of-missense-and-nonsense-mutation-abundances-for-the-us-cancer-patient-population/354086/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-catalogue-of-missense-and-nonsense-mutation-abundances-for-the-us-cancer-patient-population/354086.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How are mutation abundances estimated for the U.S. cancer patient population?","Question",{"text":63,"@type":64},"The study combines genomic data with population-level cancer abundances, using proportional reweighting to estimate overall missense and nonsense mutation abundance within the U.S. cancer patient population.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which mutations are reported as the most common in the U.S. cancer patient population?",{"text":68,"@type":64},"BRAFV600E (5.2%) is the most common mutation, TP53 R175H (1.5%) is the most common tumor suppressor mutation, and APC R876X (0.4%) is the most common nonsense mutation.",{"name":70,"@type":61,"acceptedAnswer":71},"Why do these results differ from typical pan-cancer analyses?",{"text":72,"@type":64},"Because pan-cancer analyses include cancer types in proportions that do not match population-level incidence, the mutation frequencies can be biased relative to what would be expected for a specific population.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354086,1791916594,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":55,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","medRxiv preprint doi: [https://doi.org/10.64898/2026.04.20.26351248](https://doi.org/10.64898/2026.04.20.26351248); this version posted April 22, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-NC-ND 4.0 International license .  \nA catalogue of missense and nonsense mutation abundances for the U.S. cancer  \npatient population  \nAdith S. Arun1 , David Liarakos2 , Gaurav Mendiratta2 , Thomas McFall3 , Diana C. Hargreaves4 , Geo@rey M. Wahl5 , Jiancheng Hu6,7 , Edward C. Stites1,8,9*  \n1. Yale School of Medicine, New Haven, CT USA  \n2. Integrative Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA  \n3. Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI  \n4. Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA  \n5. Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA  \n6. Division of Cellular and Molecular Research, National Cancer Centre Singapore, 30 Hospital Boulevard, 168583, Singapore, Singapore  \n7. Cancer and Stem Cell Program, Duke-NUS Medical School, 8 College Road, 169857, Singapore, Singapore  \n8. Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT USA  \n9. Yale Cancer Center, Yale School of Medicine, New Haven, CT USA  \n* Correspondence: [edward.stites@yale.edu](edward.stites@yale.edu)  \n1  \nNOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.64898/2026.04.20.26351248](https://doi.org/10.64898/2026.04.20.26351248); this version posted April 22, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-NC-ND 4.0 International license .  \nABSTRACT  \nWidespread genomic sequencing e@orts have characterized the molecular foundations of the di@erent cancers. By combining these genomic data in a manner proportional to the population-level abundances of these di@erent cancers, we estimate the overall abundances of each observed missense and nonsense mutation within the U.S. cancer patient population. We ﬁnd BRAFV600E (5.2%) is the most common mutation in the cancer patient population, TP53 R175H (1.5%) is the most common tumor suppressor mutation, andAPC R876X (0.4%) is the most common nonsense mutation. These values di@er largely and signiﬁcantly from what would be found in a typical pan-cancer analysis, where di@erent cancer types are included out of proportion to population level incidence.  \nWe present the full ordered lists of population-level abundances for speciﬁc missense and nonsense mutations, and we demonstrate the value of these data by further analyzing high priority genes (e.g., TP53 , KRAS, BRAF) and pathways (e.g., RTK/RAS, PI3K, and WNT/β -catenin) . Overall, this information is a resource that should beneﬁt the basic science, translational, and clinical cancer research communities.  \nmedRxiv preprint doi: [https://doi.org/10.64898/2026.04.20.26351248](https://doi.org/10.64898/2026.04.20.26351248); this version posted April 22, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-NC-ND 4.0 International license .  \nINTRODUCTION  \nAggregated cancer genomic data, as are found in published pan-cancer analyses (1- 4) and cancer genomic databases (5-7), have provided informative portrayals of cancer biology across many forms of cancer. The aggregate proportion of samples with a mutation in these pan-cancer databases and resources has commonly been used as a","cbCains7hUxcNdG1","https://ap.wps.com/l/cbCains7hUxcNdG1","pdf",4065701,58,"English","# Abstract\n# Introduction\n## Population-level cancer mutation frequency challenge\n## Reweighting approach and its limitations","[{\"question\":\"How are mutation abundances estimated for the U.S. cancer patient population?\",\"answer\":\"The study combines genomic data with population-level cancer abundances, using proportional reweighting to estimate overall missense and nonsense mutation abundance within the U.S. cancer patient population.\"},{\"question\":\"Which mutations are reported as the most common in the U.S. cancer patient population?\",\"answer\":\"BRAFV600E (5.2%) is the most common mutation, TP53 R175H (1.5%) is the most common tumor suppressor mutation, and APC R876X (0.4%) is the most common nonsense mutation.\"},{\"question\":\"Why do these results differ from typical pan-cancer analyses?\",\"answer\":\"Because pan-cancer analyses include cancer types in proportions that do not match population-level incidence, the mutation frequencies can be biased relative to what would be expected for a specific population.\"}]","A catalogue of missense and nonsense mutation abundances for the U.S. cancer patient population | PDF",1790108842,146,[147,151,155,159,163,167],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eb24c72d4a5d70578a341b992b2464b.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9857fb0b492be3600d13369cf39b60ae.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d449124cba54518a908f1a82875764b1.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5c78b28a846c7328907108efb9e0119.webp",980,1268,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a18cb57ea7cafa8014a761a6bbe83985.webp",979,1267,{"page_no":55,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8a47c0e3b382c80e4eab03f10171ffa.webp",978,1265]